Skip to main content

Table 7 Optimal (integral) latency, LRT and ERR, including "city", by dose range

From: Reanalysis of cancer mortality in Japanese A-bomb survivors exposed to low doses of radiation: bootstrap and simulation methods

Dose range

Site

Φm

LRT2p-con

at Φm

LRT2p-lin

at Φm

ERR1

at Φm

Latency Range

ERR0.025

at Φm

Latency Range

0-20

Stom

11

13.02

p = 0.007

12.27

p = 0.003

0.38 (0.11, 0.70)

(0.16, 0.65)*

5-18

5-21*

9-21nl

0.34 (0.11, 0.63)

(0.14, 0.59)*

5-21

5-21*

5-500

Stom

8

9.03

p = 0.025

5.74

p = 0.07

0.29 (0.06, 0.60)

(0.09, 0.55)*

7-9

5-11*

  

0-20

Liver

37

28.41

p < 10-7

18.96

p < 10-4

1.26 (0.61, 2.14)

(0.69, 1.97)*

29-43

29-43*

29-41nl

0.68 (0.18, 1.25)

(0.24, 1.20)*

29-44

29-44*

5-500

Liver

37

14.47

p = 0.003

10.55

p = 0.005

0.74 (0.25, 1.43)

(0.32, 1.30)*

34-41

34-42*

34-41nl

  

0-20

Lung

16

10.43

p = 0.03

7.13

p = 0.05

1.00 (0.36, 1.84)

(0.42, 1.72)*

10-21

10-21*

12-16nl

0.80 (0.21, 1.66)

(0.28, 1.53)*

10-16

10-21*

5-500

Lung

16

21.69

p < 10-4

19.63

p < 10-5

1.33 (0.67, 2.22)

(0.73, 2.10)*

7-21

7-21*

12-21nl

  

0-20

Panc

10

14.89

p = 0.002

13.7

p < 0.001

11.32 (5.35, 16.46)

(5.44, 15.60)*

5-11

5-11*

7-11nl

10.77 (4.21, 16.05)

(4.70, 15.31)*

5-11

5-11*

5-500

Panc

42

1.97

p = 0.64

1.96

p = 0.38

0.44 (-, -)

-

  

0-20

Leuk

25

21.66

p < 10-4

21.66

p < 10-5

1.39 (0.09, 4.31)

(0.26, 3.79)*

24-25

24-26*

17-36nl

0.89 (0.11, 2.22)

(0.16, 2.16)*

19-33

17-33*

5-500

Leuk

28

14.76

p < 0.001

8.60

p = 0.013

1.83 (0.45, 3.92)

(0.59, 3.66)*

24-31

24-32*

24-28nl

  
  1. Dose range: data on which the two-phase model is fitted, including "city" as a control covariate
  2. Φm: latency, restricted to integers 5, 6,... 44, which maximises LRT2p-con subject to ERR1 ≥ 0
  3. LRT2p-con: Likelihood Ratio Test comparison of two-phase and control models at Φm. p values derived from Table 8
  4. LRT2p-lin: Likelihood Ratio Test comparison of two-phase and linear models at Φm. p values derived from Table 8
  5. ERR1: Excess Relative Risk at 10 mSv, from the two-phase model fitted across the dose range with latency Φm, and its BCa 95%CI (5000 replications)
  6. Latency range: integral latency range around Φm for which BCa 95%CI is strictly positive
  7. *: BCa 90%CIs (5000 replications)
  8. nl: integral latency range around Φm for which LRT2p-lin > 6
  9. ERR0.025: as above, for 0.25 mSv (computed only when Dose range = 0-20 mSv)